Detection of extended-spectrum β-lactamases by using boronic acid as an AmpC β-lactamase inhibitor in clinical isolates of Klebsiella spp. and Escherichia coli

Wonkeun Song, Kwon Bae Il, You Nae Lee, Chae Hoon Lee, Hee Lee Sang, Hoon Jeong Seok

Research output: Contribution to journalArticle

61 Citations (Scopus)

Abstract

We evaluated highly sensitive methods using boronic acid (BA) to detect extended-spectrum β-lacta-mase (ESBL) production. A total of 182 clinical isolates of Klebsiella spp. (n = 118) and Escherichia coli (n = 64) were analyzed: 62 harbored only ESBLs, 80 harbored both ESBLs and plasmid-mediated AmpC β-lactamases (pAmpCs), and 40 harbored only pAmpCs. The CLSI confirmatory test detected all isolates that produce only ESBLs but detected 85% of isolates that produce both enzymes. When a ≥5-mm increase in the zone diameter of either the cefotaxime (CTX) or the ceftazidime (CAZ) disk in the presence of both clavulanic acid (CA) and BA was considered to be a positive result, the test detected all isolates that harbor ESBLs (± pAmpCs) but showed frequent false-positive results (50%) for isolates that produce only pAmpCs. Meanwhile, when a ≥3-mm increase in the zone diameter of either the CTX/BA or the CAZ/BA disk in the presence of CA was considered to be a positive result, the test also detected all isolates that harbor ESBLs (± pAmpCs) and showed less frequent false-positive results (5%) in isolates that produce only pAmpCs. The latter new interpretive guideline has enhanced detection of ESBLs in clinical isolates of Klebsiella spp. and Escherichia coli and allowed detection of an ESBL even when potentially masked by a pAmpC.

Original languageEnglish
Pages (from-to)1180-1184
Number of pages5
JournalJournal of Clinical Microbiology
Volume45
Issue number4
DOIs
Publication statusPublished - 2007 Apr 1

Fingerprint

Boronic Acids
Klebsiella
Plasmids
Escherichia coli
Clavulanic Acid
Ceftazidime
Cefotaxime
Guidelines
Enzymes

All Science Journal Classification (ASJC) codes

  • Microbiology (medical)

Cite this

@article{54ac97ea22ad41bdb98e84d89281039a,
title = "Detection of extended-spectrum β-lactamases by using boronic acid as an AmpC β-lactamase inhibitor in clinical isolates of Klebsiella spp. and Escherichia coli",
abstract = "We evaluated highly sensitive methods using boronic acid (BA) to detect extended-spectrum β-lacta-mase (ESBL) production. A total of 182 clinical isolates of Klebsiella spp. (n = 118) and Escherichia coli (n = 64) were analyzed: 62 harbored only ESBLs, 80 harbored both ESBLs and plasmid-mediated AmpC β-lactamases (pAmpCs), and 40 harbored only pAmpCs. The CLSI confirmatory test detected all isolates that produce only ESBLs but detected 85{\%} of isolates that produce both enzymes. When a ≥5-mm increase in the zone diameter of either the cefotaxime (CTX) or the ceftazidime (CAZ) disk in the presence of both clavulanic acid (CA) and BA was considered to be a positive result, the test detected all isolates that harbor ESBLs (± pAmpCs) but showed frequent false-positive results (50{\%}) for isolates that produce only pAmpCs. Meanwhile, when a ≥3-mm increase in the zone diameter of either the CTX/BA or the CAZ/BA disk in the presence of CA was considered to be a positive result, the test also detected all isolates that harbor ESBLs (± pAmpCs) and showed less frequent false-positive results (5{\%}) in isolates that produce only pAmpCs. The latter new interpretive guideline has enhanced detection of ESBLs in clinical isolates of Klebsiella spp. and Escherichia coli and allowed detection of an ESBL even when potentially masked by a pAmpC.",
author = "Wonkeun Song and Il, {Kwon Bae} and Lee, {You Nae} and Lee, {Chae Hoon} and Sang, {Hee Lee} and Seok, {Hoon Jeong}",
year = "2007",
month = "4",
day = "1",
doi = "10.1128/JCM.02322-06",
language = "English",
volume = "45",
pages = "1180--1184",
journal = "Journal of Clinical Microbiology",
issn = "0095-1137",
publisher = "American Society for Microbiology",
number = "4",

}

Detection of extended-spectrum β-lactamases by using boronic acid as an AmpC β-lactamase inhibitor in clinical isolates of Klebsiella spp. and Escherichia coli. / Song, Wonkeun; Il, Kwon Bae; Lee, You Nae; Lee, Chae Hoon; Sang, Hee Lee; Seok, Hoon Jeong.

In: Journal of Clinical Microbiology, Vol. 45, No. 4, 01.04.2007, p. 1180-1184.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Detection of extended-spectrum β-lactamases by using boronic acid as an AmpC β-lactamase inhibitor in clinical isolates of Klebsiella spp. and Escherichia coli

AU - Song, Wonkeun

AU - Il, Kwon Bae

AU - Lee, You Nae

AU - Lee, Chae Hoon

AU - Sang, Hee Lee

AU - Seok, Hoon Jeong

PY - 2007/4/1

Y1 - 2007/4/1

N2 - We evaluated highly sensitive methods using boronic acid (BA) to detect extended-spectrum β-lacta-mase (ESBL) production. A total of 182 clinical isolates of Klebsiella spp. (n = 118) and Escherichia coli (n = 64) were analyzed: 62 harbored only ESBLs, 80 harbored both ESBLs and plasmid-mediated AmpC β-lactamases (pAmpCs), and 40 harbored only pAmpCs. The CLSI confirmatory test detected all isolates that produce only ESBLs but detected 85% of isolates that produce both enzymes. When a ≥5-mm increase in the zone diameter of either the cefotaxime (CTX) or the ceftazidime (CAZ) disk in the presence of both clavulanic acid (CA) and BA was considered to be a positive result, the test detected all isolates that harbor ESBLs (± pAmpCs) but showed frequent false-positive results (50%) for isolates that produce only pAmpCs. Meanwhile, when a ≥3-mm increase in the zone diameter of either the CTX/BA or the CAZ/BA disk in the presence of CA was considered to be a positive result, the test also detected all isolates that harbor ESBLs (± pAmpCs) and showed less frequent false-positive results (5%) in isolates that produce only pAmpCs. The latter new interpretive guideline has enhanced detection of ESBLs in clinical isolates of Klebsiella spp. and Escherichia coli and allowed detection of an ESBL even when potentially masked by a pAmpC.

AB - We evaluated highly sensitive methods using boronic acid (BA) to detect extended-spectrum β-lacta-mase (ESBL) production. A total of 182 clinical isolates of Klebsiella spp. (n = 118) and Escherichia coli (n = 64) were analyzed: 62 harbored only ESBLs, 80 harbored both ESBLs and plasmid-mediated AmpC β-lactamases (pAmpCs), and 40 harbored only pAmpCs. The CLSI confirmatory test detected all isolates that produce only ESBLs but detected 85% of isolates that produce both enzymes. When a ≥5-mm increase in the zone diameter of either the cefotaxime (CTX) or the ceftazidime (CAZ) disk in the presence of both clavulanic acid (CA) and BA was considered to be a positive result, the test detected all isolates that harbor ESBLs (± pAmpCs) but showed frequent false-positive results (50%) for isolates that produce only pAmpCs. Meanwhile, when a ≥3-mm increase in the zone diameter of either the CTX/BA or the CAZ/BA disk in the presence of CA was considered to be a positive result, the test also detected all isolates that harbor ESBLs (± pAmpCs) and showed less frequent false-positive results (5%) in isolates that produce only pAmpCs. The latter new interpretive guideline has enhanced detection of ESBLs in clinical isolates of Klebsiella spp. and Escherichia coli and allowed detection of an ESBL even when potentially masked by a pAmpC.

UR - http://www.scopus.com/inward/record.url?scp=34247263339&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34247263339&partnerID=8YFLogxK

U2 - 10.1128/JCM.02322-06

DO - 10.1128/JCM.02322-06

M3 - Article

C2 - 17301276

AN - SCOPUS:34247263339

VL - 45

SP - 1180

EP - 1184

JO - Journal of Clinical Microbiology

JF - Journal of Clinical Microbiology

SN - 0095-1137

IS - 4

ER -